Moderna said March 10 it has begun the first human trial of a modified version of its COVID-19 vaccine designed to combat a variant of the virus, The Wall Street Journal reported.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,